Small dense low‐density lipoprotein as biomarker for atherosclerotic diseases

EA Ivanova, VA Myasoedova… - Oxidative medicine …, 2017 - Wiley Online Library
Low‐density lipoprotein (LDL) plays a key role in the development and progression of
atherosclerosis and cardiovascular disease. LDL consists of several subclasses of particles …

Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions

JB Daleprane, DS Abdalla - Evidence‐Based Complementary …, 2013 - Wiley Online Library
Propolis has attracted attention in recent years due to its beneficial effects, which make it a
potential preventive and therapeutic agent as well as a useful additive in food and …

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review

IT Silva, APQ Mello, NRT Damasceno - Lipids in health and disease, 2011 - Springer
The association of cardiovascular events with Lp-PLA 2 has been studied continuously
today. The enzyme has been strongly associated with several cardiovascular risk markers …

The oxidized lipoproteins in vivo: Its diversity and behavior in the human circulation

H Itabe, T Obama - International Journal of Molecular Sciences, 2023 - mdpi.com
A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known
as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) …

LDL as a cause of atherosclerosis

GH Tomkin, D Owens - The Open Atherosclerosis & Thrombosis …, 2012 - benthamopen.com
The low density lipoprotein particle is the major transporter of cholesterol around the body
and has been shown to be a strong independent risk factor for atherosclerotic events. This …

Applications of recombinant Pichia pastoris in the healthcare industry

D Weinacker, C Rabert, AB Zepeda… - Brazilian Journal of …, 2013 - SciELO Brasil
Since the 1970s, the establishment and development of the biotech industry has improved
exponentially, allowing the commercial production of biopharmaceutical proteins …

Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke

J Pelisek, HH Eckstein, A Zernecke - Archivum immunologiae et therapiae …, 2012 - Springer
Stroke is among the major causes of mortality and disabilities in the world. About 80% of all
strokes in the anterior circulation are ischemic and up to 20% of all ischemic strokes are …

Probiotic soy product supplemented with isoflavones improves the lipid profile of moderately hypercholesterolemic men: a randomized controlled trial

D Cardoso Umbelino Cavallini… - Nutrients, 2016 - mdpi.com
Background: Cardiovascular disease is the leading cause of worldwide morbidity and
mortality. Several studies have demonstrated that specific probiotics affect the host's …

Treatment of dyslipidemias to prevent cardiovascular disease in patients with type 2 diabetes

M Khavandi, F Duarte, HN Ginsberg… - Current cardiology …, 2017 - Springer
Abstract Purpose of Review Current preventive and treatment guidelines for type 2 diabetes
have failed to decrease the incidence of comorbidities, such as dyslipidemia and ultimately …

[HTML][HTML] Effects of probiotics on the lipid profile: Systematic review

CJMU Gadelha, AN Bezerra - Jornal vascular brasileiro, 2019 - SciELO Brasil
As alterações na microbiota intestinal podem modular mecanismos envolvendo fatores de
risco para doenças cardiovasculares, incluindo as dislipidemias. O objetivo foi revisar os …